Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05595850 · ClinicalTrials.gov registry record · NA

A Mindful Community for People With ALS and Their Primary Caregivers

A NA study, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT05595850 is a NA study that has completed, run by Harvard University. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05595850, a NA study, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The psychological impact of ALS on patients and caregivers is high, significantly affecting their quality of life (QOL). Despite this impact, there is not much research about psychological interventions that could reduce psychological distress and improve QOL. The efficacy of mindfulness-based treatments for the improvement of QOL was previously demonstrated by the investigator's group. Despite preliminary positive results, treatment efficacy tends to weaken over time. The investigators believe that a robust solution to maintain efficacy is to maximize the utilization of technology and emerging social platforms, establishing a "mindful community" to promote and continuously reinforce mindfulness. This project's primary aims are 1) to develop a "mindful" online community of people with ALS and their caregivers, and 2) to test its efficacy in QOL improvement. This two-part intervention consists of 1) optimizing the investigator's prior e-learning platform with a three-week program including cognitive exercises, videos and lectures to increase participants' mindfulness; and 2) involving participants in a "mindfulness community" within a social sharing forum. Assessments will be performed before and immediately post-treatment as well as 3- and 6-months post-program comparing subjects undergoing the intervention to a control group.

Interventions

  • BEHAVIORAL Mindfulness
  • BEHAVIORAL Mindful Learning

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-05-15
Est. Completion 2025-04-10
Phase NA

Sponsor

Harvard University

37 total trials

What the Registry Record Tells You About NCT05595850

The ClinicalTrials.gov registry entry for NCT05595850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mindfulness is the first listed.

NCT05595850 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05595850 about?

NCT05595850 is a clinical study titled "A Mindful Community for People With ALS and Their Primary Caregivers". The psychological impact of ALS on patients and caregivers is high, significantly affecting their quality of life (QOL). Despite this impact, there is not much research about psychological interventions that could reduce psychological distress and improve QOL. The efficacy of mindfulness-based trea...

What is the current status of trial NCT05595850?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-05-15. Estimated completion is 2025-04-10.

What interventions are being tested in trial NCT05595850?

The interventions under investigation include: Mindfulness (BEHAVIORAL), Mindful Learning (BEHAVIORAL).

Who is sponsoring clinical trial NCT05595850?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.